314140.KS · 알피바이오
South Korea · RS rating 37 · As of 2026-10-14
| Price | 5,500.00 KRW |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 29 / 44 / 37 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 21 / 45 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +13.9% |
| Sales growth Q/Q | +13.2% |
| Distance from 52-week high | +31.3% |
| Market cap (USD) | $38.1M |